Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Myelin oligodendrocyte glycoprotein (MOG) antibodies"'
Publikováno v:
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background The diagnosis of immunoglobulin G serum antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) associated inflammatory demyelinating disorders can be confirmed by the presence of MOG-IgG, yet its general cut-off concentration
Externí odkaz:
https://doaj.org/article/a76adce3b9144e33986f4629325f73b1
Autor:
Helen Cross, Farahna Sabiq, Nathalie Ackermans, Andrew Mattar, Shelly Au, Mark Woodhall, Bo Sun, Virginia Devonshire, Robert Carruthers, Ana Luiza Sayao, Virender Bhan, Alice Schabas, Jillian Chan, Marvin Fritzler, Patrick Waters, Anthony Traboulsee
Publikováno v:
Frontiers in Neurology, Vol 11 (2021)
Introduction: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease is a recently described central nervous system (CNS) inflammatory disorder with phenotypic overlap with Neuromyelitis Optica Spectrum Disorder (NMOSD). NMOSD seronega
Externí odkaz:
https://doaj.org/article/0af20205d7e7454387e5ce5355f07913
Autor:
S. Jarius, F. Paul, O. Aktas, N. Asgari, R. C. Dale, J. de Seze, D. Franciotta, K. Fujihara, A. Jacob, H. J. Kim, I. Kleiter, T. Kümpfel, M. Levy, J. Palace, K. Ruprecht, A. Saiz, C. Trebst, B. G. Weinshenker, B. Wildemann
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-10 (2018)
Abstract Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brains
Externí odkaz:
https://doaj.org/article/1dfbca0b7d634be58a08cea01226cdfb
Autor:
Marianna Pezzella, Valentino Manzo, Sergio Ferrari, Elisa Capone, Michele Spiniello, Massimo Napolitano, Lia Allegorico, Giorgia Teresa Maniscalco, Sara Mariotto, Lidia Altomare, Gennaro Alfieri, Giovanna Servillo, Rosaria Renna, Angelo Ranieri
Publikováno v:
Neurological Sciences. 42:1531-1534
Anti-myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are new emerging diseases with heterogeneous course, treatment, response, and prognosis. We herein present 2 cases with antibodies to MOG, one with a cerebellar/brainstem
Autor:
Nathalie Ackermans, Farahna Sabiq, Patrick Waters, Virginia Devonshire, Robert Carruthers, Ana Luiza Sayao, Shelly Au, Jillian Chan, Andrew A Mattar, Marvin J. Fritzler, Helen Cross, Bo Sun, Virender Bhan, Mark Woodhall, Anthony Traboulsee, Alice Schabas
Publikováno v:
Frontiers in Neurology
Frontiers in neurology, Vol. 11, p. 525933 [1-12] (2021)
Frontiers in Neurology, Vol 11 (2021)
Frontiers in neurology, Vol. 11, p. 525933 [1-12] (2021)
Frontiers in Neurology, Vol 11 (2021)
Introduction: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease is a recently described central nervous system (CNS) inflammatory disorder with phenotypic overlap with Neuromyelitis Optica Spectrum Disorder (NMOSD). NMOSD seronega
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-5 (2021)
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-5 (2021)
Background The diagnosis of immunoglobulin G serum antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) associated inflammatory demyelinating disorders can be confirmed by the presence of MOG-IgG, yet its general cut-off concentration had not
Autor:
Diego Franciotta, Brian G. Weinshenker, I. Kleiter, J. de Seze, Brigitte Wildemann, Friedemann Paul, Ho Jin Kim, C. Trebst, Michael J. Levy, Nasrin Asgari, Jacqueline Palace, Albert Saiz, Sven Jarius, Orhan Aktas, Klemens Ruprecht, T. Kümpfel, Anu Jacob, Kazuo Fujihara, Russell C. Dale
Publikováno v:
Jarius, S, Paul, F, Aktas, O, Asgari, N, Dale, R C, de Seze, J, Franciotta, D, Fujihara, K, Jacob, A, Kim, H J, Kleiter, I, Kümpfel, T, Levy, M, Palace, J, Ruprecht, K, Saiz, A, Trebst, C, Weinshenker, B G & Wildemann, B 2018, ' MOG-Enzephalomyelitis : Internationale Empfehlungen zu Diagnose und Antikörpertestung ', Der Nervenarzt, bind 89, nr. 12, s. 1388–1399 . https://doi.org/10.1007/s00115-018-0607-0
Mittels sogenannter zellbasierter Assays konnte in den vergangenen Jahren durch zahlreiche Arbeitsgruppen unabhangig eine robuste Assoziation von Immunglobulin-G-Autoantikorpern gegen menschliches Voll-Langen-Myelin-Oligodendrozyten-Glykoprotein (MOG
Autor:
Annette Spreer, Katrin Pape, Sven G. Meuth, Julia Loos, Frauke Zipp, Stefan Bittner, Felix Luessi, Steffen Pfeuffer, Tobias Ruck
Publikováno v:
Journal of Neurology
BackgroundBased on clinical, immunological and histopathological evidence, MOG-IgG-associated encephalomyelitis (MOG-EM) has emerged as a distinct disease entity different from multiple sclerosis (MS) and aquaporin-4-antibody-positive neuromyelitis o
Autor:
S. Jarius, B. Wildemann
Publikováno v:
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-30 (2019)
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-30 (2019)
Neuromyelitis optica (NMO) was long considered a clinical variant of multiple sclerosis (MS). However, the discovery of a novel and pathogenic anti-astrocytic serum autoantibody targeting aquaporin-4 (termed NMO-IgG or AQP4-Ab), the most abundant wat
Autor:
Nicola De Rossi, Maria Donata Benedetti, Marco Zoccarato, Antonino Pavone, Marco Turatti, Luigi Zuliani, Luisa Grazian, Markus Reindl, Daniela Alberti, GianPietro Sechi, Alessia Farinazzo, Roberto Bombardi, Massimiliano Calabrese, Elia Sechi, Luciano Deotto, Sara Mariotto, Sergio Ferrari, Alberto Polo, Kathrin Schanda, Raffaella Tanel, Morena Cadaldini, Rachele Delogu, Ruggero Capra, Daniele Urso, Chiara Rosa Mancinelli, Gaetano Cantalupo, Alberto Gajofatto, Francesco Janes, Maria Rachele Bianchi, Adriana Bonora, Salvatore Monaco
Publikováno v:
Journal of Neurology
Anti-myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) recently emerged as a potential biomarker in patients with inflammatory demyelinating diseases of the central nervous system. We here compare the clinical and laboratory findings observed i